Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OXE-103 for Acute Concussion Management
NCT04558346Phase 2Completed
- Start
- Oct 2020
- Primary completion
- Oct 2022
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SUN11031 in concussion (mTBI). Started Oct 2020; status: completed.
02
Drugs
SUN11031
03
Conditions
concussion (mTBI)
Beyond the preview
Go deeper on NCT04558346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04558346.